Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with EverolimusChun‐Ping Chang, Ya‐Hui Chi|Molecular Cancer Therapeutics|2024Cited by 9